Contact us to learn more about Vycellix Sweden and our cell-based immunotherapeutic products.
Immunotherapies
Vycellix Sweden AB is a wholly-owned subsidiary of the USA-based biotechnology company, Vycellix, Inc. Vycellix Sweden is engaged in discovery-stage cancer immunotherapy research, which is conducted in collaboration with leading medical researchers at Sweden’s Karolinska Institutet. The Company’s mission is to discover and develop novel therapeutic products for the improved treatment of human disease with a focus on cancers.